Teleflex Inc. (TFX: Quote) announced that its Semprus BioSciences subsidiary has been issued CE certification from its notified body, the DEKRA Certification Group of The Netherlands, to market the company's Nylus Peripherally Inserted Central Catheter or PICC with Semprus Sustain technology to the European Union.
The Nylus PICC uses a long-lasting polymer designed to reduce the attachment of platelets and blood proteins at the surface of the medical device. This provides benefits to the patient, the caregiver and the health care system, the company said.
The Nylus PICC has been shown to reduce platelet adhesion and thrombus accumulation through in vitro and animal testing.
Click here to receive FREE breaking news email alerts for Teleflex Inc and others in your portfolio
by RTT Staff Writer
For comments and feedback: email@example.com